Ordaos creates bespoke mini-proteins to help drug hunters deliver life-saving treatments.
Ordaos Bio has raised $338K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Ordaos Bio's investors include IAG Capital Partners, Future Labs, Middleland Capital, Route 66 Ventures, Citta Capital.
Ordaos Bio is headquartered in Manhattan, United States.
Ordaos creates bespoke mini-proteins to help drug hunters deliver life-saving treatments.
Ordaos Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ordaos Bio — Funding & Investors." VCBacked, April 1, 2025, https://www.vcbacked.co/company/ordaos-bio. Accessed August 14, 2026.
VCBacked. (2025). Ordaos Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ordaos-bio
{{cite web |title=Ordaos Bio — Funding & Investors |url=https://www.vcbacked.co/company/ordaos-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated